U.S. could approve Pfizer COVID-19 vaccine for kids age 5-11 in October: sources

The timeline is in accordance with the expectancy that Pfizer could have sufficient information from scientific trials to hunt emergency use authorization for that age staff by way of the top of this month.

Leave a Reply

Your email address will not be published. Required fields are marked *